Navigation Links
Spherix Announces 2010 Financial Results
Date:3/30/2011

BETHESDA, Md., March 30, 2011 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies – today reported financial results for the year ended December 31, 2010.

Recent and Upcoming Highlights

  • Pharmaceutical Development
  • Announced the signing of a multi-unit research contract to investigate the role of D-tagatose in lowering triglycerides
  • Announced results from its first Phase 3 trial post hoc analysis for D-tagatose in the treatment of Type 2 diabetes
  • Seeking a strategic relationship with a pharmaceutical company for the continued clinical development of D-tagatose as a treatment for Type 2 diabetes and triglycerides
  • Raised $5.25 million in a registered direct offering of preferred stock and warrants
  • Raised $2.77 million in a registered direct offering of common stock and warrants
  • Recent and upcoming trade and professional shows:
  • Spherix's President, Dr. Robert Lodder, presented and participated at the Windhover Therapy Area Conference held November 3-4, 2010 in Boston
  • January 11, 2011: Dr. Lodder presented at OneMedForum SF 2011 and at Biotech Showcase 2011, both in San Francisco
  • February 15, 2011: Dr. Lodder presented at the 13th Annual BIO CEO & Investor Conference in New York; with Spherix's CEO, Dr. Claire Kruger, in attendance
  • March 31, 2011: Dr. Lodder will be presenting at the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference to be held in New York

  • Health Sciences Consulting
  • Recent and upcoming trade and professional shows:
  • October 23, 2010: Dr. Kruger presented "Stevia...The Science Behind the
    '/>"/>

  • SOURCE Spherix Incorporated
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
    2. Spherix Transfers Stock Listing to Nasdaq Capital Market
    3. Spherix Reports 3rd Quarter Earnings
    4. Spherix Announces 2008 Financial Results
    5. Spherix Recruiting New Independent Director to Regain NASDAQ Compliance
    6. Spherix Incorporated Announces the Death of A. Paul Cox, Jr., Chairman of the Board
    7. Spherix to Exhibit at the BIO 2009 International Convention
    8. Spherix Regains Full NASDAQ Compliance
    9. Spherix Announces Full-Scale Production of Pharmaceutical Tagatose
    10. Spherix Announces Termination of Arla License Agreement
    11. Spherix Reports Second Quarter 2009 Earnings
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/28/2015)... MADISON, N.J. , May 28, 2015  Quest ... provider of diagnostic information services, announced that it is ... Conference in New York.  Steve Rusckowski , the ... goals and five point strategy.  The presentation is scheduled ... Time. The presentation will be webcast live ...
    (Date:5/28/2015)... , May 27, 2015 Research and ... Jain PharmaBiotech,s new report "Cell Therapy - ... This report describes and evaluates cell ... to play an important role in the practice ... the old fashioned bone marrow transplants. Role of ...
    (Date:5/28/2015)... , May 28, 2015 Natera, Inc., ... a study published in Ultrasound in Obstetrics ... polymorphism (SNP)-based non-invasive prenatal test (NIPT) can identify ... A study based upon data ... pregnancies occur in about 1 in 1,000 pregnancies, ...
    (Date:5/28/2015)... , May 28, 2015 RXi Pharmaceuticals Corporation ... discovering and developing innovative therapeutics, primarily in the areas ... a public offering of 26 million units at a ... gross proceeds of approximately $10.4 million. Each unit consists ... 13-month overallotment purchase right to purchase 0.50 of a ...
    Breaking Biology Technology:Quest Diagnostics to Speak at the Jefferies 2015 Global Healthcare Conference 2Global Cell Therapy Market 2015-2020 - Technologies, Markets and Companies 2First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 2First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 3RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 3
    ... to Vote FOR Amylin Director Nominees on the ... Contest SAN DIEGO, May 15 Amylin Pharmaceuticals, ... the following statement in response to a report ... regarding Amylin,s Annual Meeting of Stockholders to be ...
    ... Nile Therapeutics, Inc. (Nasdaq: ... novel therapeutics for heart failure patients, received notification from ... agency has released the Company,s CD-NP development program from ... to the FDA the finalized protocol for the Company,s ...
    ... Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical ... filed a shelf registration statement on Form S-3 with ... effective by the SEC, will allow Poniard from time ... million aggregate amount of its common stock, common stock ...
    Cached Biology Technology:Amylin Comments on RiskMetrics Report 2Amylin Comments on RiskMetrics Report 3Amylin Comments on RiskMetrics Report 4Amylin Comments on RiskMetrics Report 5Nile Therapeutics CD-NP Clinical Program for Acute Heart Failure Released From Clinical Hold by FDA 2Nile Therapeutics CD-NP Clinical Program for Acute Heart Failure Released From Clinical Hold by FDA 3Poniard Pharmaceuticals Files Shelf Registration 2Poniard Pharmaceuticals Files Shelf Registration 3
    (Date:5/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/2w6zgs/facial ) has ... Market by Solution, by Software, by Hardware, by ... report to their offering. The last ... more efficient and cost effective. This has helped ... the commercial sector. The development of 3D facial ...
    (Date:5/28/2015)... 28, 2015 Industry analyst firm n-tech ... report titled "Markets for Self-Healing Materials: 2015-2022." According to ... and vascular systems, biomaterials, relevant shape memory materials ... $2.7 billion by 2020. The report ... of smart materials. Other recent n-tech reports have included ...
    (Date:5/27/2015)... 2015   Codonics (codonics.com), a ... image documentation solutions and Omnicell  (omnicell.com), ... solutions, is pleased to announce their state ... Label System® (SLS), an award-winning FDA class ... Omnicell Anesthesia Workstation, helps prevent medication errors, ...
    Breaking Biology News(10 mins):Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4
    ... team has used commercially available gene chips to ... small defects that cause genetic diseases. Because currently ... the new research may lead to more accurate ... lead to mental retardation. , "For years, many ...
    ... of the Carnegie Institution and Stanford University, explained advances ... achievable to reduce costs and multiply current levels of ... presented his talk, "Bioenergy: The 21st Century Challenge to ... Society of Plant Biologists (ASPB) today (4:30 p.m. Eastern ...
    ... the U.S. Department of Energy's Brookhaven National Laboratory, ... Pharmaceuticals, Inc., have determined the atomic crystal structure ... eliminating unwanted, non-nutritional compounds such as drugs, industrial ... detailed mechanism of action will help scientists understand ...
    Cached Biology News:Speeding the search for elusive chromosomal errors 2Speeding the search for elusive chromosomal errors 3Speeding the search for elusive chromosomal errors 4Scientific issues associated with carbon-neutral energy sources such as cellulosic ethanol 2Scientists take 'snapshots' of enzyme action 2
    ... Comments: Ab-1 stains tumor cells of embryonal carcinoma ... of germ cell tumors like seminoma. Glandular epithelium ... positive. Luminal and endocrine cells of stomach and ... are also positive. Epitope: Carbohydrate portion ...
    ... Endogenous potent vasoconstrictor peptide. Displays ... modulates vascular tonus. ET-1, ET-2, and ET-3 ... genes. ET-2 and ET-3 are similar to ... amino acids, respectively. All three isopeptides produce ...
    HP 1 alpha Immunogen: Synthetic peptide between amino acids 1-100 of the human HP 1 alpha protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
    ... siSolutions siRNA Custom Synthesis ... effective duplex RNA to knockdown ... 21-mers (19 RNA base pairs ... recently-published 27-mers, or other lengths ...
    Biology Products: